Evidence map›Paper›PMID 29849866›Full record

ArticleOxidative medicine and cellular longevity2018

R(+)-Thioctic Acid Effects on Oxidative Stress and Peripheral Neuropathy in Type II Diabetic Patients: Preliminary Results by Electron Paramagnetic Resonance and Electroneurography.

Simona Mrakic-Sposta, Alessandra Vezzoli, Luca Maderna, Francesca Gregorini, Michela Montorsi, Sarah Moretti, Fulvia Greco, Emanuela Cova, Maristella Gussoni

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. The Role of Oxidative Stress in Peripheral Neuropathy.Journal of molecular neuroscience : MN · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Advances in the Relationship Between Pyroptosis and Diabetic Neuropathy.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Simona Mrakic-SpostaInstitute of Bioimaging and Molecular Physiology, National Council of Research (CNR), Segrate, Italy.ORCID 0000-0001-7359-2690
Alessandra VezzoliInstitute of Bioimaging and Molecular Physiology, National Council of Research (CNR), Segrate, Italy.
Luca MadernaIstituto Auxologico Italiano, Milan, Italy.
Francesca GregoriniIstituto Auxologico Italiano, Milan, Italy.
Michela MontorsiInstitute of Bioimaging and Molecular Physiology, National Council of Research (CNR), Segrate, Italy.ORCID 0000-0001-5152-761X
Sarah MorettiInstitute of Bioimaging and Molecular Physiology, National Council of Research (CNR), Segrate, Italy.ORCID 0000-0002-9208-017X
Fulvia GrecoInstitute for Macromolecular Studies, National Council of Research (CNR), Milan, Italy.
Emanuela CovaIRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Maristella GussoniInstitute for Macromolecular Studies, National Council of Research (CNR), Milan, Italy.ORCID 0000-0002-5836-7249
Institute of Molecular Bioimaging and Physiology · ITInstitute for Macromolecular Studies · ITIRCCS Istituto Auxologico Italiano · ITPoliclinico San Matteo Fondazione · ITUninett (Norway) · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDiabetic neuropathy is the most common complication of diabetes. The idea of alterations in energy metabolism in diabetes is emerging. The biogenic antioxidant R(+)-thioctic acid has been successfully used in the treatment of diabetic polyneuropathic (DPN) patients.

methodsThe effects of R(+)-thioctic acid (1 tablet, 1.6 g) administration were evaluated in 12 DPN patients at baseline and at 15, 30, 60, and 120 administration days throughout the assessment of oxidative stress (OxS); ROS production rate by electron paramagnetic resonance (EPR) technique; and oxidative damage biomarkers (thiobarbituric acid reactive substances (TBARS) and protein carbonyls (PC)), electroneurography (ENG) and visual analogue scale.

resultsSupplementation induced significant changes (

conclusionThe results strongly indicate that an increased antioxidant capacity plays an important role in OxS, nerve conduction velocity, pain, and general wellness improvement. Nevertheless, the effects of the antioxidant compound were found positive up to 60 days. Then, a hormesis effect was observed. Novelty of the research would be a challenge for investigators to carefully address issues, including dose range factors, appropriate administration time, and targeting population to counteract possible "boomerang effects." The great number of monitored parameters would firmly stress these conclusions.

Indexed as

AgedAntioxidantsDiabetes Mellitus, Type 2Diabetic NeuropathiesElectric StimulationElectron Spin Resonance SpectroscopyHumansOxidative StressThioctic AcidAntioxidantsThioctic Acid

Identifiers

PMID29849866
PMCPMC5914101
OpenAlexW2798013221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.